by Damon Race | Feb 5, 2021 | In the News
by WRAL TechWire — January 29, 2021 RESEARCH TRIANGLE PARK – More than 100 startups and emerging entrepreneurial companies will participate in the Venture Connect 2021 summit, the Council for Entrepreneurial Development announced today. The event is set for March...
by Damon Race | Jan 19, 2021 | Press
January 12, 2021 Damon R. Race, President & CEO RALEIGH, NC – GeneVentiv Therapeutics, a gene therapy company developing a safe, effective and durable, single infusion treatment for all types of hemophilia with or without inhibitors, today announced the...
by Damon Race | Nov 30, 2020 | In the News
Latest spinoff from UNC’s Gene Therapy Center wants to find a cure for hemophilia Read more here: https://www.newsobserver.com/news/business/article247379109.html#storylink=cpy RALEIGH UNC-Chapel Hill’s gene therapy center has birthed yet another startup in the...
by Damon Race | Nov 6, 2020 | In the News
By Seth Thomas Gulledge – Staff Writer, Triangle Business Journal – November 4, 2020 Companies in this article: University of North Carolina at Chapel Hill https://www.unc.edu/, GeneVentiv Therapeutics https:/www.geneventiv.com A new company launching around...
by Damon Race | Nov 6, 2020 | In the News
by Meredith Dockery, North Carolina Business News Wire — November 4, 2020 . RALEIGH — GeneVentiv Therapeutics, Inc., a gene therapy developer, announced a license agreement with the University of North Carolina at Chapel Hill for a patent-pending, gene therapy for...
Recent Comments